Crossref
journal-article
Public Library of Science (PLoS)
PLoS ONE (340)
References
50
Referenced
49
10.1007/BF00310370
/ Acta Neuropathol / On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. by JJ Martin (1994)10.1038/ng0997-65
/ Nat Genet / Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. by G David (1997)10.1016/S0022-510X(03)00209-0
/ J Neurol Sci / The hereditary adult-onset ataxias in South Africa. by A Bryer (2003)10.1038/nm1298
/ Nat Med / 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. by M Waza (2005)10.1523/JNEUROSCI.5453-06.2007
/ J Neurosci / A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes. by M Latouche (2007)10.1093/hmg/ddm213
/ Hum Mol Genet 16 Spec / Polyglutamine diseases: emerging concepts in pathogenesis and therapy. by J Shao (2007)10.1093/hmg/ddl148
/ Hum Mol Genet / Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. by PS Thomas (2006)10.1093/hmg/ddi147
/ Hum Mol Genet / Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. by JM Van Raamsdonk (2005)10.1007/s12311-008-0027-y
/ Cerebellum / Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration. by GA Garden (2008)10.1371/journal.pone.0003341
/ PLoS ONE / Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. by S Alves (2008)10.1038/nm1076
/ Nat Med / RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. by H Xia (2004)10.1073/pnas.0501507102
/ Proc Natl Acad Sci USA / RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. by SQ Harper (2005)10.1093/hmg/ddg280
/ Hum Mol Genet / Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. by A Abdelgany (2003)10.1073/pnas.1231012100
/ Proc Natl Acad Sci USA / Allele-specific silencing of dominant disease genes. by VM Miller (2003)10.1101/gad.862301
/ Genes Dev / RNA interference is mediated by 21- and 22-nucleotide RNAs. by SM Elbashir (2001)10.1038/nsmb780
/ Nat Struct Mol Biol / Kinetic analysis of the RNAi enzyme complex. by B Haley (2004)10.1371/journal.pgen.0020140
/ PLoS Genet / Designing siRNA that distinguish between genes that differ by a single nucleotide. by DS Schwarz (2006)10.1046/j.1474-9728.2003.00054.x
/ Aging Cell / Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. by H Ding (2003)10.1093/nar/gki312
/ Nucleic Acids Res / A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. by Q Du (2005)10.1073/pnas.0601309103
/ Proc Natl Acad Sci USA / Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. by DM Dykxhoorn (2006)10.1093/nar/gkh208
/ Nucleic Acids Res / Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. by VM Miller (2004)10.1016/j.gene.2005.11.006
/ Gene / Allele-specific silencing of Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations. by X Feng (2006)10.1016/j.nbd.2006.04.019
/ Neurobiol Dis / Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo. by X Xia (2006)10.1038/nbt.1539
/ Nat Biotechnol / Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. by J Hu (2009)10.1093/hmg/11.2.175
/ Hum Mol Genet / Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. by NJ Caplen (2002)10.1111/j.1399-0004.2006.00680.x
/ Clin Genet / Origin of the SCA7 gene mutation in South Africa: implications for molecular diagnostics. by J Greenberg (2006)10.1083/jcb.200511045
/ J Cell Biol / PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. by A Janer (2006)10.1093/hmg/10.22.2569
/ Hum Mol Genet / Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. by C Zander (2001)10.1261/rna.1062908
/ RNA / Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. by RL Boudreau (2008)10.1038/nature04791
/ Nature / Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. by D Grimm (2006)10.1073/pnas.0801775105
/ Proc Natl Acad Sci USA / Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. by JL McBride (2008)10.1038/mt.2008.82
/ Mol Ther / Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. by A Ely (2008)10.1038/mt.2008.231
/ Mol Ther / Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. by RL Boudreau (2009)10.1128/MCB.01248-06
/ Mol Cell Biol / Specific isoforms of translation initiation factor 4GI show differences in translational activity. by MJ Coldwell (2006)10.1371/journal.pone.0002248
/ PLoS ONE / Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. by Y Ohnishi (2008)10.1016/S0092-8674(03)00801-8
/ Cell / Functional siRNAs and miRNAs exhibit strand bias. by A Khvorova (2003)10.1016/S0092-8674(03)00759-1
/ Cell / Asymmetry in the assembly of the RNAi enzyme complex. by DS Schwarz (2003)10.1261/rna.546207
/ RNA / Effect of target secondary structure on RNAi efficiency. by Y Shao (2007)10.1038/mt.2008.144
/ Mol Ther / Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic. by JC Giering (2008)10.1038/nature02998
/ Nature / Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. by M Arrasate (2004)10.1038/sj.embor.7400250
/ EMBO Rep / Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. by C Landles (2004)10.1093/hmg/ddh139
/ Hum Mol Genet / Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. by D Helmlinger (2004)10.1016/S0896-6273(01)00422-6
/ Neuron / Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. by AR La Spada (2001)10.1073/pnas.0503505102
/ Proc Natl Acad Sci USA / Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. by VB Palhan (2005)10.1038/mt.2009.17
/ Mol Ther / Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. by RL Boudreau (2009)10.1002/ana.21569
/ Ann Neurol / Sustained effects of nonallele-specific Huntingtin silencing. by V Drouet (2009)10.1017/S1355838202021362
/ RNA / Functional siRNA expression from transfected PCR products. by D Castanotto (2002)10.1073/pnas.082243699
/ Proc Natl Acad Sci USA / A monomeric red fluorescent protein. by RE Campbell (2002)10.1261/rna.2299306
/ RNA / Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. by C An (2006)10.1093/hmg/8.5.731
/ Hum Mol Genet / Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. by DL Stenoien (1999)
Dates
Type | When |
---|---|
Created | 15 years, 11 months ago (Sept. 29, 2009, 1:48 p.m.) |
Deposited | 6 years, 10 months ago (Oct. 23, 2018, 2:12 p.m.) |
Indexed | 3 months ago (May 28, 2025, 1:23 p.m.) |
Issued | 15 years, 10 months ago (Sept. 30, 2009) |
Published | 15 years, 10 months ago (Sept. 30, 2009) |
Published Online | 15 years, 10 months ago (Sept. 30, 2009) |
@article{Scholefield_2009, title={Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype}, volume={4}, ISSN={1932-6203}, url={http://dx.doi.org/10.1371/journal.pone.0007232}, DOI={10.1371/journal.pone.0007232}, number={9}, journal={PLoS ONE}, publisher={Public Library of Science (PLoS)}, author={Scholefield, Janine and Greenberg, L. Jacquie and Weinberg, Marc S. and Arbuthnot, Patrick B. and Abdelgany, Amr and Wood, Matthew J. A.}, editor={Cookson, Mark R.}, year={2009}, month=sep, pages={e7232} }